Recent Advancements of Bortezomib in Acute Lymphocytic Leukemia Treatment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Advancements of Bortezomib in Acute Lymphocytic Leukemia Treatment
Authors
Keywords
-
Journal
ACTA HAEMATOLOGICA
Volume 129, Issue 4, Pages 207-214
Publisher
S. Karger AG
Online
2013-01-04
DOI
10.1159/000345260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
- (2012) Y. H. Messinger et al. BLOOD
- Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells
- (2012) Danian Nie et al. LEUKEMIA & LYMPHOMA
- Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells
- (2011) Ai-Hua Wang et al. ANNALS OF HEMATOLOGY
- Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker
- (2011) Rajan Dewar et al. CANCER BIOLOGY & THERAPY
- A Phase I Clinical-Pharmacodynamic Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with the Proteasome Inhibitor Bortezomib in Advanced Acute Leukemias
- (2011) J. E. Lancet et al. CLINICAL CANCER RESEARCH
- The critical role of JNK in the ER-mitochondrial crosstalk during apoptotic cell death
- (2011) Gaurav Verma et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Proteasome Inhibitor Bortezomib Enhances ATRA-Induced Differentiation of Neuroblastoma Cells via the JNK Mitogen-Activated Protein Kinase Pathway
- (2011) Peihua Luo et al. PLoS One
- Biology of acute lymphoblastic leukemia (ALL): Clinical and therapeutic relevance
- (2011) Carlos Graux TRANSFUSION AND APHERESIS SCIENCE
- Acute Lymphoblastic Leukemia in Elderly Patients: A Single Institution's Experience
- (2011) Dong-Yeop Shin et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia
- (2010) Maddalena Paganin et al. BLOOD REVIEWS
- BCL-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress
- (2010) Girija Dasmahapatra et al. CANCER BIOLOGY & THERAPY
- The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
- (2010) Lluis Espinosa et al. CANCER CELL
- Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
- (2010) J. J. Wright CLINICAL CANCER RESEARCH
- The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia
- (2010) P. Saunders et al. HAEMATOLOGICA
- Recent Research Advances in Childhood Acute Lymphoblastic Leukemia
- (2010) Ching-Hon Pui JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium
- (2010) Yoav Messinger et al. PEDIATRIC BLOOD & CANCER
- Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL-Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors
- (2009) Z. Jagani et al. CANCER RESEARCH
- Bortezomib
- (2009) Monique P. Curran et al. DRUGS
- Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
- (2009) Richard H. Ko et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B and 14 for childhood acute lymphoblastic leukemia
- (2009) C H Pui et al. LEUKEMIA
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
- (2008) A. Moricke et al. BLOOD
- Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
- (2008) E. C. Attar et al. CLINICAL CANCER RESEARCH
- Mechanism of Synergy of N-(4-Hydroxyphenyl)Retinamide and ABT-737 in Acute Lymphoblastic Leukemia Cell Lines: Mcl-1 Inactivation
- (2008) Min H. Kang et al. JNCI-Journal of the National Cancer Institute
- Treatment of Adult Acute Lymphoblastic Leukemia
- (2008) Nicola Gökbuget et al. SEMINARS IN HEMATOLOGY
- Relapsed acute lymphoblastic leukemia: Current status and future opportunities
- (2008) Theresa M. Harned et al. Current Oncology Reports
- Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program
- (2007) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started